ORIX to Issue Unsecured Debt Securities Denominated in U.S. Dollars
TOKYO, Japan – September 4, 2024 – ORIX Corporation (“ORIX”) announced today its decision to issue
unsecured senior debt securities denominated in U.S. dollars under the terms and conditions outlined below.
This offshore debt funding will be conducted by ORIX pursuant to a shelf registration statement filed on Form
F-3 with the U.S. Securities and Exchange Commission (“SEC”) as part of its strategy to secure funding flexibilityand diversification of funding sources. ORIX will raise funds from overseas investors.
5 year notes
Total amount of notes
Interest rate
Issue price
Payment date
Maturity

USD $700,000,000
4.65% per annum
99.987% of the principal amount
September 10, 2024
September 10, 2029

Contact Information:
Investor Relations and Sustainability Department
ORIX Corporation
Tel: +81-3-3435-3121

About ORIX Group:
ORIX Group (ORIX Corporation TSE: 8591; NYSE: IX) was established in 1964 and has grown from its roots in leasing in Japan to become
a global, diverse, and unique corporate group. Today, it is active around the world in financing and investment, life insurance, banking,asset management, real estate, concession, environment and energy, automobile-related services, industrial/ICT equipment, shipsand aircraft. Since expanding outside of Japan in 1971, ORIX Group has grown its business globally and now operates in around 30
countries and regions across the world with approximately 34,000 people. ORIX Group unites globally around its Purpose: “FindingPaths. Making Impact.” combining diverse expertise and innovative thinking to help our world develop in a sustainable way. For moredetails, please visit our website: https://www.orix.co.jp/grp/en/(As of March 31, 2024)

Caution Concerning Forward Looking Statements:
These documents may contain forward-looking statements about expected future events and financial results that involve risks anduncertainties. Such statements are based on our current expectations and are subject to uncertainties and risks that could cause
actual results that differ materially from those described in the forward-looking statements. Factors that could cause such a difference
include, but are not limited to, those described under “Risk Factors” in the Company’s annual report on Form 20-F filed with theUnited States Securities and Exchange Commission and under “(4) Risk Factors” of the “1. Summary of Consolidated Financial Results”
of the “Consolidated Financial Results April 1, 2023 –March 31, 2024” furnished on Form 6-K.

This material does not constitute an offer for sale, or a solicitation for purchase, of any securities. Securities may not be offeredor sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, asamended. Any public offering of our securities to be made in the United States will be made by means of a prospectus that may
be obtained from us and that will contain detailed information about us and our management, as well as our financial statements.
A registration statement (including a prospectus, No. 333-273159) to which this communication relates has been filed with theSEC and is effective. No offer or sale of our securities shall take place in Japan.